Ascendis Pharma A/S

Ascendis Pharma A/S

248.00
EUR
+4.00
(+1.64%)
13.36EPS
14.56P/E
13.25BMarket Cap
Feb 17Next Earn

Ascendis Pharma A/S Documents

Q2 FY2024 · Press release

Ascendis Pharma A/S - Investor Update - Report · 4 pages

Read Ascendis Pharma A/S's results firsthand

Preview the first 2 pages of this press release
Create a free account to start reading

Full documents are included with Professional

Q2 FY2024 documents